ProfileGDS4718 / 217153_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 45% 48% 45% 49% 47% 44% 51% 52% 47% 50% 45% 45% 52% 46% 47% 49% 48% 45% 47% 47% 55% 48% 50% 45% 46% 47% 47% 45% 47% 50% 47% 44% 54% 51% 47% 47% 52% 53% 50% 44% 50% 53% 47% 47% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.2542145
GSM549102patient 115, normal, homogenized [OPG study]5.4250248
GSM549104patient 119, normal, homogenized [OPG study]5.2484845
GSM549108patient 138, normal, homogenized [OPG study]5.494249
GSM549119patient 077, normal, homogenized [OPG study]5.3483347
GSM549133patient 032, cancer, homogenized [OPG study]5.1211944
GSM549139patient 042, cancer, homogenized [OPG study]5.5460351
GSM549099patient 107, normal, homogenized [OPG study]5.6267752
GSM549109patient 139, normal, homogenized [OPG study]5.3727147
GSM549110patient 046, normal, homogenized [OPG study]5.5353350
GSM549114patient 063, normal, homogenized [OPG study]5.2169145
GSM549122patient 082, normal, homogenized [OPG study]5.23545
GSM549134patient 033, cancer, homogenized [OPG study]5.5985152
GSM549136patient 036, cancer, homogenized [OPG study]5.2103546
GSM549140patient 044, cancer, homogenized [OPG study]5.2993547
GSM549111patient 047, normal, homogenized [OPG study]5.4572249
GSM549113patient 057, normal, homogenized [OPG study]5.3324348
GSM549132patient 031, cancer, homogenized [OPG study]5.2347945
GSM549137patient 038, cancer, homogenized [OPG study]5.3440847
GSM549142patient 047, cancer, homogenized [OPG study]5.4523147
GSM549100patient 110, normal, homogenized [OPG study]5.8143555
GSM549107patient 135, normal, homogenized [OPG study]5.3813948
GSM549115patient 068, normal, homogenized [OPG study]5.4733350
GSM549116patient 072, normal, homogenized [OPG study]5.2120745
GSM549120patient 078, normal, homogenized [OPG study]5.2691146
GSM549131patient 030, cancer, homogenized [OPG study]5.2993547
GSM549118patient 074, normal, homogenized [OPG study]5.3440847
GSM549129patient 027, cancer, homogenized [OPG study]5.2665145
GSM549123patient 088, normal, homogenized [OPG study]5.3438347
GSM549124patient 006, cancer, homogenized [OPG study]5.5526850
GSM549126patient 015, cancer, homogenized [OPG study]5.3358447
GSM549128patient 025, cancer, homogenized [OPG study]5.1504744
GSM549103patient 117, normal, homogenized [OPG study]5.7681654
GSM549117patient 073, normal, homogenized [OPG study]5.5130151
GSM549138patient 041, cancer, homogenized [OPG study]5.3163347
GSM549141patient 045, cancer, homogenized [OPG study]5.3095647
GSM549130patient 028, cancer, homogenized [OPG study]5.650752
GSM549101patient 111, normal, homogenized [OPG study]5.6943953
GSM549105patient 128, normal, homogenized [OPG study]5.5456350
GSM549106patient 134, normal, homogenized [OPG study]5.1384244
GSM549112patient 048, normal, homogenized [OPG study]5.4944550
GSM549125patient 011, cancer, homogenized [OPG study]5.6804153
GSM549127patient 024, cancer, homogenized [OPG study]5.3756847
GSM549135patient 035, cancer, homogenized [OPG study]5.3333847